It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2015.
2015 | Hyderabad, Telangana, India | ActiveGbr Laboratories Private Limited, a active private limited company, was established on 15 July 2015 in Hyderabad, Telangana, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24100TG2015PTC099794. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹7.00 Cr.
It upholds a compliant status. Its leadership includes Gaddam Samhitha Pratapreddy (Director), Gaddam Padma Reddy (Director), Madaalasa Pratapreddy Gaddam (Additional Director). Past directors included Nithun Reddy Gaddam, Gaddam Samhitha Pratapreddy. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hno.5-7-209/2,Sri Puram Colony,Bn Reddy Nagar Vanasthalipuram, Hyderabad, Telangana, 500070.
U24100TG2015PTC099794
099794
15 July 2015
₹7.00 Cr
₹7.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Gbr Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaddam Samhitha Pratapreddy | Director | 30 Jan 2021 | Current |
| Gaddam Padma Reddy | Director | 15 Jul 2015 | Current |
| Madaalasa Pratapreddy Gaddam | Additional Director | 22 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jan 2021 | Past |
| Pramod Abcsdd | Director | 18 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gbr Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.71% increase. The company also saw a substantial fall in profitability, with a 2256.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 93.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Gbr Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2025 | Others | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Gbr Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gbr Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gbr Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Madaalasa Pratapreddy Gaddam was appointed as a Additional Director was appointed as a Additional Director on 22 Apr 2025 & has been associated with this company since 7 months 13 days . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101061321 was registered on 05 Mar 2025. was completed.
Gbr Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Gbr Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Gaddam Samhitha Pratapreddy was appointed as a Director was appointed as a Director on 30 Jan 2021 & has been associated with this company since 4 years 10 months . was completed.
Progress on Gaddam Padma Reddy was appointed as a Director was appointed as a Director on 15 Jul 2015 & has been associated with this company since 10 years 4 months . was documented.
The CIN of Gbr Laboratories Private Limited is U24100TG2015PTC099794.
Gbr Laboratories Private Limited is headquartered at Hno.5-7-209/2,Sri Puram Colony,Bn Reddy Nagar Vanasthalipuram, Hyderabad, Telangana, 500070.
Gbr Laboratories Private Limited was incorporated on 15 July 2015.
The current directors of Gbr Laboratories Private Limited are
The primary industry of Gbr Laboratories Private Limited is Pharma.
Gbr Laboratories Private Limited is unlisted.
The authorized capital of Gbr Laboratories Private Limited is ₹7.00 Cr, and the paid-up capital is ₹7.00 Cr.
The compliance status of Gbr Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX